期刊
INTERNATIONAL JOURNAL OF CANCER
卷 126, 期 8, 页码 1817-1827出版社
WILEY
DOI: 10.1002/ijc.24847
关键词
colon cancer; tristetraprolin; VEGF; tumor growth; angiogenesis
类别
资金
- Grant sponsor: Korea Research Foundation [KRF2007-J00301]
- Grant sponsor: Glsan University Hospital (Biomedical Research Center Promotion Fund) [UUH-2006-2]
- Grant sponsor: Ministry of Health & Welfare, Republic of Korea [A050742]
- Korea Health Promotion Institute [A050742] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
Tristetraprolin (TIP) is an AU-rich element-binding protein that regulates mRNA stability. Here, we report that TIP suppress the growth of human colon cancer cells both in vivo and in vitro by regulating of the expression of vascular endothelial growth factor (VEGF). TTP protein expression in human colonic tissues was markedly decreased in colonic adenocarcinoma compared with in normal mucosa and adenoma. VEGF expression was higher in colonic adenocarcinoma than in normal mucosa and adenoma. Specific inhibition of UP expression by RNA-interference increased the expression of VEGF in cultured human colon cancer cells, and TTP overexpression markedly decreased it. In addition, elevated expression of TIP decreased the expression level of luciferase linked to a 3' terminal AU-rich element (ARE) of VEGF mRNA. Colo320/TTP cells overexpressing TIP grew slowly in vitro and became tumors small in size when xenografted s.c into nude mice. These findings demonstrate that TIP acts as a negative regulator of VEGF gene expression in colon cancer cells, suggesting that it can be used as novel therapeutic agent to treat colon cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据